Safety of benzodiazepine or Z-hypnotic exposure in early pregnancy
- PMID: 37353251
- DOI: 10.1016/S2215-0366(23)00158-X
Safety of benzodiazepine or Z-hypnotic exposure in early pregnancy
Conflict of interest statement
I declare no competing interests. Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations.
Comment on
-
Association between maternal benzodiazepine or Z-hypnotic use in early pregnancy and the risk of stillbirth, preterm birth, and small for gestational age: a nationwide, population-based cohort study in Taiwan.Lancet Psychiatry. 2023 Jul;10(7):499-508. doi: 10.1016/S2215-0366(23)00148-7. Lancet Psychiatry. 2023. PMID: 37353262
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources